Form 8-K - Current report:
SEC Accession No. 0001628280-25-012899
Filing Date
2025-03-17
Accepted
2025-03-17 06:13:38
Documents
31
Period of Report
2025-03-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zntl-20250315.htm   iXBRL 8-K 35084
2 EX-99.1 final-xzntlupdatedclinical.htm EX-99.1 21137
3 EX-99.2 simpkins_sgoxdenalixpart.htm EX-99.2 17369
8 image_0.jpg GRAPHIC 7116
9 simpkins_sgoxdenalixpart001.jpg GRAPHIC 93342
10 simpkins_sgoxdenalixpart002.jpg GRAPHIC 161089
11 simpkins_sgoxdenalixpart003.jpg GRAPHIC 82135
12 simpkins_sgoxdenalixpart004.jpg GRAPHIC 47233
13 simpkins_sgoxdenalixpart005.jpg GRAPHIC 113739
14 simpkins_sgoxdenalixpart006.jpg GRAPHIC 122827
15 simpkins_sgoxdenalixpart007.jpg GRAPHIC 123551
16 simpkins_sgoxdenalixpart008.jpg GRAPHIC 134691
17 simpkins_sgoxdenalixpart009.jpg GRAPHIC 135313
18 simpkins_sgoxdenalixpart010.jpg GRAPHIC 110729
19 simpkins_sgoxdenalixpart011.jpg GRAPHIC 109421
20 simpkins_sgoxdenalixpart012.jpg GRAPHIC 113748
21 simpkins_sgoxdenalixpart013.jpg GRAPHIC 121587
22 simpkins_sgoxdenalixpart014.jpg GRAPHIC 157871
  Complete submission text file 0001628280-25-012899.txt   2484330

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zntl-20250315.xsd EX-101.SCH 2039
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zntl-20250315_def.xml EX-101.DEF 4226
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zntl-20250315_lab.xml EX-101.LAB 24316
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zntl-20250315_pre.xml EX-101.PRE 16232
33 EXTRACTED XBRL INSTANCE DOCUMENT zntl-20250315_htm.xml XML 2958
Mailing Address 10275 SCIENCE CENTER DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 10275 SCIENCE CENTER DRIVE SUITE 200 SAN DIEGO CA 92121 (858) 263-4333
Zentalis Pharmaceuticals, Inc. (Filer) CIK: 0001725160 (see all company filings)

EIN.: 823607803 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39263 | Film No.: 25742266
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)